Additionally, we aim to assess whether FSH priming yields different results in PCOS versus normo-ovulatory patients, a subgroup that may have different outcomes because of altered follicular and hormone milieu, and thus offering insights into patient-specific responses. Here, BRD2 is linked to polycystic ovary syndrome.